L Ramanathan
Overview
Explore the profile of L Ramanathan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
970
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
G P, Lakshmanan L, Ramanathan L
Asian Pac J Cancer Prev
. 2019 Mar;
20(3):951-960.
PMID: 30912420
Objective: In recent years, citation analysis tools provide many devices for finding or computing the citation score
or impact factor for journals. It is important for the researchers to identify...
2.
Kamalakkannan V, Puratchikody A, Ramanathan L
Res Pharm Sci
. 2013 Sep;
8(2):125-36.
PMID: 24019822
Candesartan cilexetil (CC) is a newer class of angiotensin II receptor antagonist used for the treatment of hypertension. The solubility of the CC is very poor and its oral bioavailability...
3.
Nayak S, Krishnamurthy A, Ramanathan L, Ranade A, Prabhu L, Jiji P, et al.
Clin Ter
. 2010 Jul;
161(3):249-52.
PMID: 20589356
Aim: The plantaris muscle (PM) and its tendon is subject to considerable variation in both the points of origin and of insertion. The present study was carried out to fi...
4.
Nayak S, Ramanathan L, Prabhu L, Raju S
Singapore Med J
. 2007 Jul;
48(8):e231-3.
PMID: 17657373
Anomalous muscles usually do not cause symptoms but are of academic interest. They become a surgical problem when they produce symptoms or are difficult to differentiate from soft tissue tumours....
5.
Madison V, Duca J, Bennett F, Bohanon S, Cooper A, Chu M, et al.
Biophys Chem
. 2002 Dec;
101-102:239-47.
PMID: 12488004
Removal of the N-terminal formyl group from newly synthesized proteins by the enzyme peptide deformylase (PDF) is essential for normal growth of bacteria but not higher organisms. Recently, PDF has...
6.
McCoy M, Senior M, Gesell J, Ramanathan L, Wyss D
J Mol Biol
. 2001 Feb;
305(5):1099-110.
PMID: 11162117
The backbone assignments, secondary structure, topology, and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex have been determined by NMR spectroscopy. Residues I34 to S181 of...
7.
Thannickal T, Moore R, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, et al.
Neuron
. 2000 Oct;
27(3):469-74.
PMID: 11055430
Murine and canine narcolepsy can be caused by mutations of the hypocretin (Hcrt) (orexin) precursor or Hcrt receptor genes. In contrast to these animal models, most human narcolepsy is not...
8.
Butkiewicz N, Yao N, Zhang R, Ramanathan L, Lau J, Hong Z, et al.
Biochem Biophys Res Commun
. 2000 Jan;
267(1):278-82.
PMID: 10623610
The NS3 serine protase of Hepatitis C virus (HCV) requires NS4A protein as a cofactor for efficient cleavage at four sites in the nonstructural region. The cofactor activity has been...
9.
Sali D, Ingram R, Wendel M, Gupta D, McNemar C, Tsarbopoulos A, et al.
Biochemistry
. 1998 Apr;
37(10):3392-401.
PMID: 9521660
Hepatitis C virus (HCV) protease NS3 and its protein activator NS4A participate in the processing of the viral polyprotein into its constituent nonstructural proteins. The NS3/4A complex is thus an...
10.
Zhang R, Durkin J, Windsor W, McNemar C, Ramanathan L, Le H
J Virol
. 1997 Aug;
71(8):6208-13.
PMID: 9223519
We probed the substrate specificity of a recombinant noncovalent complex of the full-length hepatitis C virus (HCV) NS3 serine protease and NS4A cofactor, using a series of small synthetic peptides...